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Duetoaclosegeneticrelatedness,thereisnoknownantibodythatdetectsMycobacterium
avium subspecies paratuberculosis (MAP), which causes Johne’s disease in cattle and
sheep, and does not cross-react with other M. avium subspecies. In the present study,
a monoclonal antibody (MAb; 17A12) was identiﬁed from mice immunized with a cell
membrane fraction of MAP strain K-10. This antibody is 100% speciﬁc as it detected a
25-kDa protein in all 29 MAP whole cell lysates, but did not bind to any of the 29 non-
paratuberculosis strains tested in immunoblot assays. However, the antibody revealed
variable reactivity levels in MAP strains as it detected higher levels in bovine isolates but
comparably lower levels in ovine isolates of MAP . In order to identify the target binding
protein for 17A12, a lambda phage expression library of MAP genomic fragments was
screened with the MAb. Four reactive clones were identiﬁed, sequenced and all shown
to be overlapping. Further analysis revealed all four clones expressed an unknown protein
encoded by a sequence that is not annotated in the K-10 genome and overlapped with
MAP3422c on the opposing DNA strand. The epitope of 17A12 was precisely deﬁned to
seven amino acids and was used to query the K-10 genome. Similarity searches revealed
another protein, encoded by MAP1025, possessed a similar epitope (one-amino acid mis-
match) that also reacted strongly to the antibody. A single nucleotide polymorphism (SNP)
in MAP1025 was then identiﬁed by comparative sequence analysis, which results in a
Pro28His change at residue 28, the ﬁrst amino acid within the 17A12 epitope.This SNP is
present in all MAP strains but absent in all non-MAP strains and accounts for the speci-
ﬁcity of the 17A12 antibody.This new antibody is the ﬁrst ever isolated that binds only to
the paratuberculosis subspecies of M. avium and opens new possibilities for the speciﬁc
detection of this signiﬁcant ruminant pathogen.
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INTRODUCTION
There are inherent diagnostic difﬁculties when a bacterial
pathogen is closely related to ubiquitous environmental microor-
ganisms. In these situations, it is difﬁcult to detect the pathogen,
but not the environmental bacteria, which would lead to false
positive results. Yet this is the case for Mycobacterium avium
subsp. paratuberculosis (hereafter referred to as MAP), a veteri-
nary pathogen that causes Johne’s disease in cattle, sheep, and
other ruminants (Harris and Barletta,2001). It belongs to a group
of closely related mycobacteria that comprise the Mycobacterium
avium complex (MAC),and the remaining members of this com-
plex play the role of environmental contaminants in a veterinary
context. The MAC group historically has consisted of Mycobac-
teriumintracellulare andallM.aviumsubspecies,includingavium,
hominissuis,paratuberculosis,andsilvaticum(Turenneetal.,2007);
however,recentlyspecieshavebeenaddedtothiscomplexbasedon
multispacersequencetypinganalysis(Cayrouetal.,2010).TheM.
avium subspecies in particular are closely related as determined
long ago by DNA–DNA hybridization studies (Yoshimura and
Graham, 1988) which led to the initial proposal to include them
as an avium subspecies (Thorel et al., 1990). More recent genome
scalestudieshavedemonstratedthathominissuis andparatubercu-
losis subspecies share greater than 98% genetic similarity among
the sequenced strains (Bannantine et al., 2003) and show only a
fewsmalldifferencesbycompetitivegenomicDNAhybridizations
to microarrays (Paustian et al.,2008).
Methods that include subtractive hybridization and compar-
ative genomics enable identiﬁcation of sequences speciﬁc to a
particularbacteriumunderstudy.ForMAP,theseapproacheshave
identiﬁed large sequence polymorphisms (LSPs), which appear
to represent the main source of genomic diversity. These LSPs
and their evolutionary implications are nicely summarized by
Marcel Behr and co-workers (Alexander et al., 2009). Single
nucleotide polymorphisms (SNPs) and nucleotide repeats have
also contributed to the genomic diversity and have resulted in
excellent strain typing methods (Bull et al., 2003; Amonsin et al.,
2004; Sevilla et al., 2008; Thibault et al., 2008; Castellanos et al.,
2009). Thus far, these differences in the DNA sequences of MAC
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organisms have yet to fully explain the phenotypic differences
inherent in each MAC member.
While a monoclonal antibody (MAb) speciﬁc to M. avium
subsp. avium has long been identiﬁed that does not cross-react
with MAP (Abe et al., 1989), no such antibodies speciﬁc to only
MAPhavebeendescribed.ThisistobeexpectedbecausetheMAP
genome, at 4.8Mb, is believed to be the smallest in the MAC
group and therefore speciﬁc gene targets are more likely avail-
able in the other subspecies with larger genomes and thus more
coding potential. In spite of this, MAbs were previously devel-
oped against a whole cell extract of MAP in an effort to obtain
a speciﬁc detection reagent. When positive hybridomas secreting
MAbs were screened against mycobacterial species in speciﬁcity
studies, nearly all cross-reacted with M. avium subspecies isolates
(Bannantine et al., 2007b). The one antibody that did not, 14D4,
surprisingly cross-reacted with more distantly related mycobacte-
rialspeciessuchasM.phlei,M.kansasii,andM.bovis.Theprotein
target that 14D4 binds to remains unknown.
An alternative strategy to obtain a speciﬁc antibody is to search
the LSP regions in MAP for genes that encode proteins with high
predicted antigenicities and then make antibodies to recombinant
proteinsrepresentingthosegeneproducts.However,thereareonly
a total of 32 genes that qualify using this criteria (Paustian et al.,
2010) and in most instances when a MAb can be obtained, it
reacts well to the recombinant protein, but does not react with
the native protein produced by MAP (Bannantine, unpublished
observations). Therefore,it is ideal to start with the native protein
when screening for such antibodies.
It has been shown previously that a surface extraction of
MAP has increased speciﬁcity and can be used to distinguish this
pathogen from other MAC members (Eda et al.,2006). Therefore,
we hypothesized that similar surface protein extracts might con-
tain speciﬁc components. We prepared a membrane extraction of
MAPandusedthatasantigenforMAbproduction.Wediscovered
a speciﬁc antibody that binds to a protein encoded by MAP1025.
Although the protein encoded by this gene is not speciﬁc to MAP,
sequenceanalysisrevealedaSNP,presentonlyinMAPstrains,that
alters the epitope.
MATERIALS AND METHODS
BACTERIAL STRAINS
A total of 58 Mycobacterium species and strains were used in this
study. These include several members of the MAC group and TB
complexaswellassomesaprophyticmycobacteria.Theyarelisted
in Table A1 in Appendix. Escherichia coli strains used for cloning
and expression are described previously (Bannantine et al.,2010).
PRODUCTION OF MONOCLONAL ANTIBODIES
Monoclonal antibodies were produced using standard methods
(Harlow and Lane, 1988). Brieﬂy, BALB/c mice were immunized
three times intraperitoneally with a membrane-enriched pro-
tein extract of MAP K-10 (100μg per injection) suspended in
0.5mL of phosphate-buffered saline (PBS; 150mM NaCl, 10mM
NaPO4, pH 7.2) at 14-day intervals. The membrane-enriched
extract was prepared as described previously (Radosevich et al.,
2007) and emulsiﬁed in Freund’s incomplete adjuvant (Sigma-
Aldrich, St. Louis, MO, USA) for all immunizations. Humoral
immune responses of each mouse were evaluated by preparative
immunoblot analysis using the membrane-enriched extract. Cell
fusions with splenic lymphocytes and myeloma cells were per-
formed on the best responder mouse. Positive antibody secreting
hybridomaswereidentiﬁedbyimmunoblotscreeningwithculture
supernatant.The17A12antibodywasimmunotypedusingisotype
kitIfromThermoScientiﬁc(Rockford,IL,USA).Thesameproce-
dure was subsequently used to generate MAbs against the puriﬁed
recombinant target protein (termed UP1 for unknown protein 1)
expressedfromclone#23(Table A2 inAppendix),whichgenerated
MAb 10D11 along with 13 other MAbs.
PRODUCTION OF RECOMBINANT PROTEIN
The full length MAP1025, MAP3422c, and truncated UP1 frag-
ments were constructed in the pMAL-c2 expression vector as
previously described (Bannantine et al., 2010). These constructs
weretransformedandexpressedaspreviouslydescribed(Bannan-
tine et al., 2010). The primers used to construct these clones are
listed in Table A2 in Appendix.
LAMBDA ZAP EXPRESSION LIBRARY SCREENING
A MAP strain ATCC19698 expression library was constructed in
the lambda ZAP phage vector (Agilent technologies-Stratagene,
La Jolla, CA, USA) using size selected fragments in the 3–6kb
range as described previously (Bannantine and Stabel,2001). The
recombinantphagewereseededonlawnsofE.coli XL1-BlueMRF’
culturedon150-mmPetriplatescontainingNZYmediamadewith
agarose as the solidifying agent according to the manufacturer’s
guidelines. The phage were diluted and plated on E. coli XL1-Blue
such that approximately 600–700plaques per plate were obtained.
After plaque formation was barely visible, the plate was overlaid
with 0.01M IPTG-coated Protran® nitrocellulose ﬁlters (Sigma-
Aldrich) and allowed to incubate for an additional hour. Filters
containingtheliftedplaqueswereplacedinblockingsolutioncon-
sisting of PBS with 2% bovine serum albumin (BSA; PBS–BSA)
overnight and screened with the 17A12 antibody (diluted 1:300 in
blocking solution) the following day. Positive plaques were picked
and processed according to the manufacturer’s guidelines (Agi-
lenttechnologies-Stratagene).Subcloningofphageinsertsintothe
pBK-CMVvectorforsequencingwasalsoperformedaccordingto
the manufacturer’s guidelines.
EPITOPE MAPPING OF 17A12 AND OTHER MONOCLONAL ANTIBODIES
To localize the epitope of MAbs obtained in this study, several
truncatedfragmentsof thetargetprotein(termedUP1)werecon-
structedandexpressedinpMAL-c2similartothatdescribedbefore
for MAP1242 (Wu et al., 2009). High-resolution epitope map-
ping was preformed using a spot array from JPT peptide (Berlin,
Germany). Ten peptides were synthesized directly on a cellulose-
β-alanine membrane (5nmol per peptide spot). The peptides that
reacted with MAbs 17A12 and 10D11 were identiﬁed by standard
immunoblot procedures as described immediately below. Bound
antibody was completely removed between experiments using the
regeneration protocol I described by the manufacturer (JPT pep-
tide). The membrane was exposed to ﬁlm for a protracted period
of time between experiments to conﬁrm no bound antibody
remained.
Frontiers in Microbiology | Cellular and Infection Microbiology July 2011 | Volume 2 | Article 163 | 2Bannantine et al. M. paratuberculosis-speciﬁc MAb
ELECTROPHORESIS, IMMUNOBLOT, AND PREPARATIVE IMMUNOBLOT
ASSAYS
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) was performed using 12% (w/v) polyacrylamide gels.
Electrophoretic transfer of proteins onto pure nitrocellulose was
accomplished with the Bio-Rad Trans Blot Cell (Bio-Rad Lab-
oratories, Richmond, CA, USA) with sodium phosphate buffer
(25mM, pH 7.8) at 0.8A for 90min. After transfer, ﬁlters were
blocked with PBS–BSA and 0.1% Tween 20, termed PBS–BSA–T.
Culture supernatants containing MAbs were diluted in PBS–BSA
and exposed to the blot at room temperature for 2h. After three
washes in PBS–BSA–T, blots were incubated for 1.5h in goat
anti-mouse-peroxidase (Thermo Scientiﬁc) diluted 1:20,000 in
PBS–BSA. Nitrocellulose blots were again washed three times
as described above and developed for chemiluminescence using
SuperSignal detection reagents (Thermo Scientiﬁc).
CONFOCAL MICROSCOPY OF M. AVIUM SUBSPECIES INFECTED
MONOCYTE-DERIVED MACROPHAGES (MDM) AND MAC-T CELLS
Bovine MDMs and MAC-T cells were seeded separately at a con-
centration of 2.0×104 cells/mL in a 24-well plate containing No.
1.5 thickness glass coverslips. All cells were incubated at 37˚C in
a humidiﬁed chamber containing 5% CO2 until conﬂuent. Prior
to cell infection, MAH 7337 was stained with 0.25μg/mL of 6-
carboxyﬂuoresceindiacetate(Sigma-Aldrich,St.Louis,MO,USA)
for 1h at 37˚C and immediately washed 3× with PBS. MAP K-
10 (pWes4) GFP expression strain and MAH 7337 infection of
bovine MDMs and MAC-T cells were conducted in a similar fash-
ion as described above with the exception of using phenol red
free media to prevent ﬂuorescence quenching in MAH invasion.
All time points were conducted in triplicate. For immunostain-
ing, cells were washed 3× with PBS at deﬁned time points and
ﬁxed using 2% paraformaldehyde at 37˚C for 5min. Cells were
immediatelywashed2×withPBScontaining1%BSAandperme-
abilizedwithice-coldmethanolfor5minat−20˚C.Nextcellswere
blockedwithPBScontaining1%BSAfor1hatroomtemperature,
washedtwicewithPBSandincubatedwith1:300dilutionof either
17A12 or 8G2 MAbs in PBS–Tween 20 overnight at 4˚C. After
incubation,cells were washed twice with PBS containing 1% BSA,
incubated with goat anti-mouse IgG conjugated to Alexa Fluor
350 (1:500; Invitrogen, Carlsbad, CA, USA) for 1h at room tem-
peratureinthedark,rewashed,andcounter-stainedwithCellMask
Deep Red plasma membrane stain (2.5μg/mL; Invitrogen, Carls-
bad, CA, USA). A ﬁnal wash step was conducted and coverslips
weremountedonglassslidesusingprolonggoldanti-fadereagent
(Invitrogen,Carlsbad,CA,USA).Coverslipsweresealedusingnail
polish and stored at 4˚C until visualization.All slides were imaged
using the Olympus Fluoview upright confocal microscope and
software (Olympus, Center Valley, PA, USA). Slide images were
taken using the following lasers: Alexa Fluor 405 or DAPI, FITC,
and Cy5. Z-series was collated for all images using a 1.0μms t e p
size and a Kalman average of 2 acquisitions. Three ﬁelds per slide
were recorded.
DENSITOMETRY ANALYSIS AND STATISTICS
Protein levels were indirectly measured by antibody binding on
immunoblots.ChemiluminescentimageswerecapturedonKodak
BioMax MR ﬁlm and scanned to obtain a digital image. Reac-
tive bands within the images were then analyzed by densitometry
usingPhotoshopCS5extendedsoftware’smeasurementtool.Pro-
teinlevelsinovineandbovinestrainswereevaluatedbyunpairedt
test.TheresultsarereportedasaP valuewhere<0.05isconsidered
signiﬁcant.
RESULTS
MONOCLONAL ANTIBODY 17A12 IS SPECIFIC TO M. AVIUM SUBSP.
PARATUBERCULOSIS
Nine positive, stable hybridomas were obtained following immu-
nization of mice with a membrane-enriched fraction of MAP as
described in the materials and methods section. MAbs present in
hybridoma culture supernatants were tested for reactivity against
several whole cell extracts of mycobacteria. One of these newly
obtained MAbs, designated 17A12, reacted only with MAP and
not with other mycobacteria (Figure 1A). The isotype for this
antibody is IgG1 kappa. While no reactivity with this antibody
was observed for other species and subspecies of mycobacteria,
including members of the MAC group, reactivity varied among
the different strains of MAP. The bovine isolate K-10 showed
strong reactivity in lane 4 whereas weak reactivity was observed
for the human isolate shown in lane 11. MAb 4B6, which detects
an unknown but conserved mycobacterial protein (Bannantine
et al., 2007b), shows the relative amounts of protein loaded in
each of those lanes. The type strain of MAP, which is another
bovine isolate, also reacted with the antibody and is shown in
lane 9.
The speciﬁcity of this antibody was a fantastic result consid-
ering the genetic similarity of these subspecies and was never
observedwithpreviouslydevelopedantibodiesraisedagainstMAP
proteins (Leid et al., 2002; Bannantine et al., 2007a,b; Malamo
et al., 2007). Therefore, additional isolates of M. avium subsp.
hominissuis and M. avium subsp. avium were collected and ana-
lyzed including an isolate from endangered pygmy rabbits in the
Columbia basin (Harrenstien et al., 2006). None of those isolates
produced any protein target detected by the MAb (Figure 1B).
WhenmoreextensiveanalysisofadditionalMAPisolatesfromdif-
ferenthostswereanalyzed,thevariablereactivitywasconﬁrmedby
densitometryanalysis(Figure1C).Thisvariabilitydidnotdepend
on the total protein as antibody to the major membrane protein
(MMP) encoded by MAP2121c was used to normalize protein
loaded. The results further show that MAb 17A12 detection levels
of the target protein from ovine strains were lower compared to
bovine strains (P <0.0003). This strain-to-strain difference was
reproducible and is either a result of epitope changes or level of
protein expression. To distinguish between these possibilities, the
targetproteinaswellasthereactiveepitopemustﬁrstbeidentiﬁed.
EXPRESSION LIBRARY SCREENING FOR THE TARGET PROTEIN
Four immunoreactive plaques were obtained when screening
a phage lambda expression library with the 17A12 antibody.
Sequence analysis of the subcloned plaque inserts demonstrated
they were all overlapping with a 1440-bp segment common to
all four clones (Figure 2A). The only annotated gene in this
1440-bp region, MAP3422c, was present in the opposite strand
relative to the lacZ promoter for all four library clones. E. coli
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FIGURE 1 | Monoclonal antibody 17A12 detects an unknown protein
(UP1) present only in M. avium subsp. paratuberculosis whole cell
extracts. Shown are immunoblots of mycobacterial whole cell extracts
exposed to MAbs. (A)The top blot was exposed to 17A12, which detects
only the three MAP strains present in lanes 4, 9, and 11.The lower blot,
labeled internal control, was exposed to MAb 4B6, which detects an
unknown but highly conserved mycobacterial protein (Bannantine et al.,
2007b) and shows the relative amounts of protein loaded in each of those
lanes.The mycobacterial whole cell antigen prep used is indicated.
Abbreviations: M, M. avium subsp. silvaticum; M. scro, M. scrofulaceum;
M. abs, M. abcessus;M .a p ,M. avium subsp. paratuberculosis;M .a a ,M.
avium subsp. avium; M. intracel, M. intracellulare. (B) UP1 is not present in
M. avium subsp. avium or M. avium subsp. hominissuis isolates.The
control blot labeled MMP in each image was exposed to a MAb previously
developed in our laboratory that binds to the major membrane protein,
which is present in all MAC species (Bannantine et al., 2007a).The upper
blots are loaded with M. avium subsp. avium isolates and the lower blots
are loaded with M. avium subsp. hominissuis isolates not analyzed in (A)
(seeTableA1 in Appendix for these strains). (C) Quantitative densitometry
was performed on several MAP strains and the M. avium subsp.
hominissuis strain 104.The results are expressed as a percent of
17A12 divided by the internal control (MMP). Error bars indicate standard
deviations of the means. Data are representative of three independent
culture replicates and error bars are standard deviation of
the mean.
subclones from these original phage clones expressed a protein
appearingasthreebandsandslightlylargerthanthenativeprotein
in MAP (Figure2B). The entire coding sequence of MAP3422c,a
pseudouridine synthase,which catalyzes the isomerization of spe-
ciﬁc uridines in an RNA molecule to pseudouridine, was cloned
into an expression vector and the resulting protein did not react
with 17A12 by immunoblot analysis (Figure 2C). The unanno-
tated ORF on the opposite strand was next cloned and expressed.
This protein, termed UP1, did react strongly with the 17A12
antibody (Figure 2C).
The UP1 ORF was only partially present in the genomic phage
clones. The size of this partial ORF is 1.2-kb and it completely
overlapswithMAP3422contheopposingorcomplementaryDNA
strand (Figure 2D). The calculated size of the translated product
from this partial ORF is 42kDa,which is much larger than the 25-
kDasizeobservedonimmunoblots(Figure1).Similaritysearches
of the nucleotide sequence showed the UP1 ORF was present in
othermycobacteria;however,thetranslatedproteinshowednosig-
niﬁcantsimilaritytoanyproteinsinthepublicdatabasesincluding
NCBI’s GenBank and SwissProt. Furthermore,there are no motifs
forUP1. Finally,analysisof theUP1sequenceusingtheconserved
domain database (CDD) search detected no conserved domains,
indicating the unique nature of this putative protein.
PRODUCTION OF ADDITIONAL MAbs TO THE UP1 PROTEIN
To further determine if the UP1 protein is indeed produced by
MAP and that 17A12 binding is not due to a non-speciﬁc reac-
tion, hybridomas were screened from mice immunized with the
truncated recombinant UP1 protein expressed from clone #23
(Figure 2D; Table A2 in Appendix). This screen identiﬁed 13
secreting hybridomas that reacted with the truncated version of
UP1. However, only one of these antibodies, 10D11, also reacted
with the native protein produced in MAP (Figure 3A).
EPITOPE MAPPING OF MONOCLONAL ANTIBODIES
A series of truncated UP1 peptides were produced from recombi-
nantexpressionclones(Table A2 inAppendix).AllMAbsobtained
in this study were mapped to these recombinant UP1 fragments.
They bound to at least three distinct epitopes as determined by
immunoblot analysis (data not shown) and shown schematically
(Figure3B). Note that both 10D11 and 17A12 had the same reac-
tivity pattern and also were the only two antibodies that reacted
with the native protein expressed by MAP. Analysis of the aligned
recombinant UP1 peptides showed the epitope was contained on
an 18-amino acid region near the C-terminal end of the ORF
(Figure 3B). Using this information, the epitopes for these two
antibodies were further mapped to determine if they are identical
and also to provide an anchor point on the protein. A set of 10
peptides was used to more precisely map the epitope, each with
one-amino acid extension (Figure 4). Analysis of both antibodies
using these peptides identiﬁed the seven amino acid linear epi-
tope as HPGGSQP (Figure4). These data demonstrated that only
this epitope appears to react with the native protein and all other
MAbs with epitopes distinct from HPGGSQP failed to react with
the native protein.
Thelackof reactivitytothenativeMAPproteinformostof the
MAbs was a cause of concern. Therefore, the epitope was used to
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FIGURE 2 | Sequence and immunological analysis of reactive library
clones. (A) Alignment of the four positive library clones.The alignment is
drawn to scale showing the overlap of clones #927 , #928, #929, and #930.
Shown beneath the base pair scale bar is the position of the only annotated
gene, MAP3422c, common to all four clones but on the opposite DNA strand
relative to the lacZ promoter. Arrows indicate direction of transcription. (B)
Immunoblot of uninduced and IPTG-induced E. coli lysates harboring the
positive library clones was exposed to MAb 17A12. Protein size markers are
indicated in the left margins and the clone number and induction status are
indicated across the top. K-10 is the MAP whole cell extract. Lane M is the
protein size markers. (C)The full length MAP3422c and a truncated section of
MAP3422 (UP1-#23) were cloned and expressed in E. coli.Whole cell extracts
of these recombinant clones were induced with IPTG analyzed by SDS-PAGE
and immunoblot analysis with 17A12. Only the recombinant UP1 reacted with
the antibody. Arrows indicate the location of the induced protein and “M”
represents protein size markers.The induction status is indicated by a positive
or negative symbol beneath the label. (D) Schematic sequence alignment
showing the positions of MAP3422c and UP1-clone #23 relative to the full
length UP1 open reading frame. Arrows indicate direction of transcription and
scale is in base pairs.
query the MAP K-10 genome using BLAST analysis. No identical
matches were discovered; however, MAP1025, encoding an RDD
familyprotein,possessedasimilarepitopewithasingleaminoacid
difference (Ser32Gln) and its calculated size is 25.0kDa, which is
within range of that observed by immunoblot of MAP sonicated
extracts.ArecombinantproteintoMAP1025wasalreadyavailable
from a previous study (Bannantine et al., 2010) so it was imme-
diately used in an immunoblot assay with 17A12. The antibody
bound very strongly to this protein (Figure 5). Collectively, these
data indicate that a mimotope was present in UP1 and the real
epitope is present in MAP1025.
THE MONOCLONAL ANTIBODY SPECIFICITY IS DUE TO A SNP WITHIN
MAP1025
Nucleotide similarity searches showed that MAP1025 was also
present in the genome of M. avium subspecies hominissuis strain
104. There are six SNPs in this 720bp gene; all are positioned
within the ﬁrst 240bp. Only two of these SNPs result in an amino
acid change and one of these was within the epitope. Sequence
alignmentsshowthataSNP(C→A)changesthecodonoftheﬁrst
amino acid in the epitope from His-28 in MAP to Pro-28 in strain
104.AdditionalisolateswerePCRampliﬁedandsequencedinthis
region. They also contained the same SNP (Figure 6; Table 1).
In total, 12 MAP isolates and 18 non-MAP MAC isolates were
sequenced. The identical SNP was present in all MAC strains
tested. These data suggest that the reason for the 17A12 speciﬁcity
is due to this non-synonymous SNP.
TheN-terminal75aminoacidsofMAP1025arestronglybiased
to proline and glycine amino acids. The ﬁrst 75 amino acids con-
sist of 46% proline and 18% glycine residues. After amino acid 75
is an RDD family domain. This family of proteins contain three
conserved amino acids: one arginine and two aspartates, hence
the name RDD family. This region also contains two predicted
transmembrane domains.
MAP1025 IS LOCATED PRIMARILY IN THE MEMBRANE
Immunoblot analysis of membrane-enriched fractions for two
MAP strains shows the target protein is predominantly present in
those fractions (Figure7A). However,MAP1025 was not detected
in the EtOH extract of MAP,which contains lipids and some pro-
teins gently removed from the surface of the bacilli and has been
shown to be an effective antigen in ELISA testing for Johne’s dis-
ease(Edaetal.,2006).Thequalityofthemembraneandcytoplasm
fractions for the ATCC19698 strain was tested with antibodies to
proteins known to be present predominantly in one fraction or
the other (Figure 7B). Finally, the 17A12 antibody did not react
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FIGURE3|P r oduction of monoclonal antibodies to the recombinant UP1
protein.Thirteen new MAbs were obtained after immunization with puriﬁed
recombinant UP1. (A) Shown are two preparative slot blots, one containing
UP1 expressed from phage clone #930 and the other MAP K-10 whole cell
extract. Only the 17A12 (slot 14) and 10D11 (slot 13) antibodies reacted with
both the native protein in K-10 and the E. coli expressed UP1. Slot
assignments: 1=14A5, 2=5H4, 3=14G5, 4=10A4, 5=14B7 , 6=14D7 ,
7=14G7 , 8=3G12, 9=3G2, 10=6F7 , 11=9C9, 12=10D2, 13=10D11, and
14 =17A12. (B) Alignment of truncated recombinant clones expressing UP1
along with a MAb reactivity table.The alignment shows the relative sizes and
position of recombinant clones expressing fragments of the UP1 protein.
Arrows indicate direction of transcription.The reactivity table indicates that
17A12 and 10D11 both bind to an 18-amino acid section of the UP1 fragment
(shaded area).The amino acids present within this shaded region are
indicated.The remaining antibodies all showed either the 9E11 or 6C9
reactivity patterns. ND, not determined.
with the Johnin puriﬁed protein derivative (PPD) prepared from
ATCC19698 at the National Veterinary Services Laboratory (data
not shown) indicating that the protein is not secreted in con-
ditions used to prepare PPD. Computational prediction of the
subcellularlocalizationof MAP1025usingthePSORTbalgorithm
(http://www.psort.org/psortb/index.html)identiﬁedMAP1025as
a membrane protein (score 9.82) with no signal peptide detected.
Collectively, these data suggest the protein is present predomi-
nantly in the membrane, is not an easily extracted component of
the cell wall,and is not secreted.
17A12 BINDS TO MAP INFECTED MACROPHAGES AND MAC-T CELLS
To conclude the study,we tested the utility of 17A12 to speciﬁcally
label MAP within infected host cells. Both MAP and M. avium
subsp. hominissuis infected macrophages and MAC–T epithelial
cells were ﬁxed and stained with either 17A12 or 8G2 antibodies.
The17A12MAbdetectsMAPininfectedMAC–Tcells(Figure8A)
andmacrophages(Figure8B),butdoesnotdetectM.aviumsubsp.
hominissuis as observed by confocal microscopy. The 8G2 control
antibodydetectedbothsubspeciesinbothhostcells.Infectedcells
were examined from 30min to 48h postinfection, but only the 1
and 24h time points are shown in Figure8. MAP1025 expression
was sustained throughout the observed time,including as early as
30min postinfection (data not shown).
DISCUSSION
Antibodies are among the most frequently used tools in basic sci-
ence research and yet no speciﬁc antibody had been developed
for MAP. This report describes the only known antibody that
speciﬁcally detects the paratuberculosis subspecies and not other
mycobacteria.Ithasbeendifﬁcultobtainingsuchanantibodydue
to the strong genetic similarity among members of this complex
as demonstrated by previous efforts (Leid et al.,2002; Bannantine
et al., 2003; Malamo et al., 2007). Development of the 17A12 spe-
ciﬁcantibodyopensnewlinesofresearchthatutilizeimmunoblot,
immunoprecipitation, ELISA, immunohistochemistry, and ﬂow
cytometric procedures. This novel antibody may now be used to
speciﬁcally enrich for MAP in environmental samples as well as
milk samples or used in diagnostic applications. It has already
shown utility in labeling MAP within infected cells (Figure 8).
Furthermore, studies to determine the presence of MAP in tis-
sue samples from any host species can now be approached with
this newly developed tool. Currently used methods to detect the
presence of MAP in human tissues include PCR ampliﬁcation of
IS900 (Kirkwood et al., 2009; Sasikala et al., 2009) and in situ
hybridization or non-speciﬁc acid fast staining (Jeyanathan et al.,
2007),but antigen detection with a speciﬁc antibody would add a
layerof certaintythattheorganismitself isactuallypresentwithin
tissues.
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FIGURE 4 | Epitope mapping of 17A12 using synthetic peptides. An
overlapping peptide array was constructed and used to precisely map the
17A12 binding site. Peptides were synthesized onto cellulose membranes
as either the full 18-amino acid peptide identiﬁed from Figure 3 or
decapeptides with one amino acid overlap.The cellulose membrane was
exposed to 17A12 or 10D11 and then processed as a standard immunoblot.
The reactive peptides, which comprise the epitope, are highlighted.The
antibody used is indicated in the right margin.
FIGURE 5 | MAP1025 reacts with MAb 17A12. SDS-PAGE and
immunoblot analysis of the MAP1025 recombinant fusion protein.The
MBP-MAP1025 fusion protein migrates at approximately 70kDa, which
agrees with predicted sizes (25kDa for MAP1025 plus 42kDa for MBP).The
MBP-LacZ control was loaded identically for both the SDS-PAGE and
immunoblot; however, MBP-MAP1025 was diluted 1:2,000 for the
immunoblot and 1:2 for SDS-PAGE. Note that the antibody only reacts with
MAP1025 and not the MBP afﬁnity tag. Kilodalton size standards are
located in the left margin. Lanes: 1, protein size standards; 2,
MBP-MAP1025; 3, MBP-LacZ.
Efforts to identify the target protein of MAb 17A12 initially led
to a non-sense ORF that was not annotated in the MAP genome.
It remains unknown as to why the expression library screen did
not initially reveal any MAP1025 expression clones. Instead, only
the four overlapping UP1 clones were obtained. The library was
constructed using Sau3AI partial digestion (Bannantine and Sta-
bel, 2001) and one possible explanation might be a potential lack
of Sau3A1 sites in the sequence surrounding MAP1025. How-
ever, analysis shows that there is one in-frame Sau3AI site at the
beginning of MAP1025 and prior to the sequence encoding the
epitope, which precludes this explanation. Nonetheless, all four
reactivelibraryclonesof UP1underwentforcedexpression,under
control of the E. coli lac promoter, and thus were detected by the
antibody. This UP1 sequence fortuitously had an epitope (HPG-
GSQP) similar to that present between residues 28 and 34 in
MAP1025 (HPGGQQP). Without this deﬁned seven-amino acid
epitope from UP1, we would not have located the real binding
partnerforthe17A12antibodyandthuswouldhaveneverknown
the reason for its speciﬁcity.
The example provided in this study serves as a word of cau-
tion when screening expression libraries. They are artiﬁcial sys-
tems designed to express cloned inserts regardless of the reading
frame or orientation. The fact that four independent clones were
obtainedusinganantibodyspeciﬁctoMAPinitiallyledtothecon-
clusionthatUP1wasreal,despitethefactthatitwasnotannotated
andhadnosimilarityinthesequencedatabases.Oursuspicionwas
raised after 14 additional MAbs were obtained to the recombinant
UP1 protein and only one of these (10D11) bound the same epi-
tope and reacted with a native protein produced in MAP. The
predicted size of UP1 also did not agree with that observed with
thenativeprotein.Finally,theUP1ORFwas100%conservedinall
subspecies of MAC. These factors prompted the continued search
for the target protein.
The elements required to produce a speciﬁc epitope is another
interestingfeatureof thisstudy.The17A12antibodywasobtained
using a membrane prep of MAP as the immunizing antigen
whereas 10D11 was obtained using recombinant UP1. Although
each antigen possessed a slightly different epitope, HPGGQQP
for MAP1025,and HPGGSQP for UP1,both antibodies bound to
both proteins. However, the MAP1025 epitope also differed by a
singleaminoacidwhencomparingtheparatuberculosis subspecies
with all other subspecies in the MAC (Pro28His), yet that change
resulted in speciﬁcity of 17A12. This suggests that His-28 is
required for 17A12 binding. Furthermore, the epitope mapping
experiment (Figure 4) shows that Pro-34 must also be present
for 17A12 recognition. Thus the beginning (His-28) as well as
the end (Pro-34) of the epitope are well deﬁned. Residue changes
within this epitope may not be as important since the Gln32Ser
change did not affect 17A12 binding. Finally, it should be noted
that 10D11 was not tested further in these studies because it was
raised to the epitope from UP1 and not the native epitope present
in MAP1025.
In general, the bovine isolates had stronger reactivity with
17A12 compared to the ovine isolates of MAP. While the cause
of thevariablereactivityamongthesetwoMAPlineageswasnever
identiﬁed, the reason is not due to changes in the epitope itself.
Sequence analysis of MAP1025 in several MAP strains, including
thoseisolatedfrombovine,humanandovinehosts,showed100%
conservation within the epitope (Figure 6). Therefore, reactivity
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FIGURE 6 | Sequence alignment of the 17A12 epitope region
reveals a non-synonymous SNP in genomic DNA. (A) Alignment
of 19 ampliﬁed products from mycobacterial genomic DNA were
compared with the 17A12 epitope.The polymorphic nucleotide is
shown in red, which results in an amino acid change from proline to
histidine. (B) Sequence chromatogram of selected mycobacterial
templates reveals sequence quality at the site of the C→A polymorphism.
The seven codons that encode the 17A12 epitope are shaded in gray.
Arrows point to the adenine nucleotide SNP present in the ﬁrst codon of the
epitope.
may be due to expression levels in those isolates and is a subject
for further study. The fact that the protein has an RDD family
motif doesnotsuggestanyobviousreasonforpotentialexpression
differences.
It has recently been discovered that the surface molecules of
MAP enable the speciﬁc detection of this organism in both a ﬂow
cytometric assay (Eda et al., 2005) as well as an ELISA format
(Speer et al., 2006). This antigen prep consists of a gentle vortex
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Table 1 | Epitopes from this study.
Epitope sequence Amino acid position Amino acid change Source Presence in mycobacteria? Reactivity with 17A12?
HPGGSQP Not appl. Gln32Ser UP1 Not expressed Yes
HPGGQQP 28–34 Pro28His MAP1025 MAP only Yes
PPGGQQP 28–34 His28Pro MAV_1202 Non-MAP only No
FIGURE 7 | MAP1025 is present primarily in the membrane. (A) Equal
amounts of protein obtained from various protein preparations were
analyzed by SDS-PAGE and immunoblot analysis. MAP1025 is detected at
higher relative abundance in the membrane-enriched fractions by
immunoblot. Protein preparations derived from both the K-10 strain and the
ATCC type strain are shown. EtOH prep is the ethanol vortex prep.
Kilodalton size standards are indicated in the left margins. (B) Control
immunoblots demonstrating the integrity of the cytosol and
membrane-enriched preps. MAb 9G10 binds to the cytoplasmic protein
isocitrate lyase (AceAB) and 14D4 detects an unknown protein present in
the membrane as demonstrated previously (Bannantine et al., 2007b).
of logarithmically growing bacilli in 80% ethanol. The extracted
surface components are then easily dried down and used as the
antigen in these assays. The components of this preparation have
notyetbeendetermined,butinitialstudiessuggestthatdiagnostic
proteins,carbohydrates,or lipids are more predominant in mem-
brane fractions or surface extractions as opposed to a whole cell
extract of the bacterium. In this study, MAP1025 was shown to
be present in membrane fractions; however,it was not detected in
the EtOH prep suggesting that it is not easily extracted from the
surface of the bacterium with this solvent.
SNPs have been used to distinguish ovine from bovine strains
using molecular subtyping techniques (Marsh et al.,1999; Castel-
lanos et al., 2009). However, no study to date has uncovered a
SNP that affects MAb binding as has been describe here. This
SNP-sensitive MAb has so far sharply divided MAP from all other
mycobacterial species. The importance of having this reagent for
research and detection of MAP cannot be underestimated and
opens new avenues of research with this pathogen. Finally, the
discovery of a novel SNP that deﬁnes MAb speciﬁcity shows the
FIGURE8|1 7A12 detects MAP K-10 but not MAH 7337 in bovine
monocyte-derived macrophages (MDMs) and MAC-T epithelial cells.
M. avium subsp. infections of MAC-T cells (A) and MDMs (B) at a 10:1 MOI
were visualized by confocal microscopy.The MAP K-10 (pWes4) expressing
GFP and ﬂuorescein-stained MAH 7337 (green) were used for infections.
17A12 immunostaining (blue) shows only MAP K-10 infection at 24-h in
MDMs and 1-h in MAC-T epithelial cells.The control antibody, 8G2, labels
MMP (blue) demonstrating infection for MAP and MAH in both cell types.
MDMs and MAC-T cells are shown in red. Arrows point to enlarged inserts
of intracellular bacteria. Magniﬁcation, ×1000.
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powerof non-synonymousSNPsinrelationtotheimmunological
response in the host.
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APPENDIX
TableA1 | Mycobacterial strains and isolates used in this study.
Isolate Organism Host Location Reference or source
K-10 M. avium subsp. paratuberculosis Bovine Feces NADC, ATCC BAA-968
19698 M. avium subsp. paratuberculosis Bovine Feces ATCC 19698
187 M. avium subsp. paratuberculosis Bovine Ileum Recent clinical isolate, NADC
523 M. avium subsp. paratuberculosis Bovine Ileum NADC, Ames, Iowa
803 M. avium subsp. paratuberculosis Bovine Ileum NADC, Ames, Iowa
3039 M. avium subsp. paratuberculosis Bovine Feces NADC, Ames, Iowa
3051 M. avium subsp. paratuberculosis Bovine Feces NADC, Ames, Iowa
3057 M. avium subsp. paratuberculosis Bovine Feces NADC, Ames, Iowa
3056 M. avium subsp. paratuberculosis Bovine Feces NADC, Ames, Iowa
5027 M. avium subsp. paratuberculosis Bovine Mesenteric LN NADC, Ames, Iowa
6011 M. avium subsp. paratuberculosis Bovine Ileum Robert Whitlock, U of Penn
47 M. avium subsp. paratuberculosis Bovine Ileum NADC, Ames, Iowa
4011 M. avium subsp. paratuberculosis Bovine IC lymph node NADC, Ames, Iowa
4007 M. avium subsp. paratuberculosis Bovine IC lymph node NADC, Ames, Iowa
3043 M. avium subsp. paratuberculosis Bovine Feces NADC, Ames, Iowa
Kay M. avium subsp. paratuberculosis Bovine Feces NADC, Ames, Iowa
4006 M. avium subsp. paratuberculosis Bovine IC lymph node NADC, Ames, Iowa
1003 M. avium subsp. paratuberculosis Bovine Lymph node NADC, Ames, Iowa
6012 M. avium subsp. paratuberculosis Bison Ileum Robert Whitlock, U of Penn
4003 M. avium subsp. paratuberculosis Bison Seminal vesicles NADC, Ames, Iowa
Linda M. avium subsp. paratuberculosis Human Ileum ATCC 43015
Ben M. avium subsp. paratuberculosis Human Intestine ATCC 43544
2244 M. avium subsp. paratuberculosis Goat
1213 M. avium subsp. paratuberculosis Goat
5401 M. avium subsp. paratuberculosis Goat
S397 M. avium subsp. paratuberculosis Ovine Ileum Recent clinical isolate, NADC
6093 M. avium subsp. paratuberculosis Ovine Ileum NADC
6094 M. avium subsp. paratuberculosis Ovine Mesenteric LN NADC
6095 M. avium subsp. paratuberculosis Ovine Ileum NADC
724 M. avium subsp. avium Chicken Liver ATCC 25291
6003 M. avium subsp. avium Chicken ATCC 35713 (TMC702)
801 M. avium subsp. avium Chicken ATCC 35719
6009 M. avium subsp. avium Bovine ATCC 35716 (TMC715)
6102 M. avium subsp. avium Deer USDA-APHIS, Ames, Iowa
6104 M. avium subsp. avium Gazelle USDA-APHIS, Ames, Iowa
6106 M. avium subsp. avium Avian CDC, Atlanta, GA
6107 M. avium subsp. avium Avian USDA-APHIS, Ames, Iowa
6108 M. avium subsp. avium Swine USDA-APHIS, Ames, Iowa
6109 M. avium subsp. avium Human CDC, Atlanta, GA
6110 M. avium subsp. avium Human CDC, Atlanta, GA
PygR M. avium subsp. avium Pygmy rabbit (17)
104 M. avium subsp. hominissuis Human Blood Luiz E. Bermudez
09-4407 M. avium subsp. hominissuis Elk NVSL
09-4994 M. avium subsp. hominissuis Swine NVSL
09-5902 M. avium subsp. hominissuis Swine NVSL
10-1519 M. avium subsp. hominissuis Dog NVSL
10-1068 M. avium subsp. hominissuis Bovine NVSL
10-1725 M. avium subsp. hominissuis Bovine NVSL
10-2173 M. avium subsp. hominissuis Bovine NVSL
6006 M. avium subsp. silvaticum Roe deer Vi-72
(Continued)
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TableA1 | Continued
Isolate Organism Host Location Reference or source
6409 M. avium subsp. silvaticum Wood pigeon Liver and spleen ATCC 49884
L948 M. abscessus ATCC 19977
19210 M. bovis Bovine Lymph node ATCC 19210
1011 M. bovis BCG Pasteur Bovine Milk ATCC 35734 (TMC1011)
6081 M. kansasii Human ATCC 12478
6010 M. intracellulare Swine ATCC 35773
6083 M. phlei ATCC 11758
6077 M. scrofulaceum Human Lymph node ATCC 19981
Abbreviations: LN, lymph node; IC, ileal cecal; NADC, National Animal Disease Center; CDC, Center for Disease Control; APHIS, Animal Plant Health Inspection
Service; ATCC, AmericanType Culture Collection.
TableA2 | Primers used in this study.
Construct Forward primer Reverse primer Product size (bp)
UP1-#1 ATCCTCTAGAGGTGATCTCAATCCTGCTGCG GCGCAAGCTTCTACACCGCCCGGGTGCAGGC 1182
UP1-#3 ATCCTCTAGAGGTGATCTCAATCCTGCTGCG GCGCAAGCTTACCGATCATCGGTGATCCGT 351
UP1-#4 ATCCTCTAGAGGTGATCTCAATCCTGCTGCG GCGCAAGCTTAGTGGTTACCGCCGACGGGGCG 927
UP1-#6 ATCCTCTAGAGATCAGCGACTCCCGGGTGCC GCGCAAGCTTCTACACCGCCCGGGTGCAGGC 1206
UP1-#7 ATCCTCTAGAGATCAGCGACTCCCGGGTGCC GCGCAAGCTTACCGGCGCCGCTGCCGGTTCGC 1077
UP1-#8 ATCCTCTAGAGATCAGCGACTCCCGGGTGCC GCGCAAGCTTACCGATCATCGGTGATCCGT 375
UP1-#10 ATCCTCTAGAGTCGACCACCGCCCCGTCGGC GCGCAAGCTTACCGGCGCCGCTGCCGGTTCGC 156
UP1-#11 ATCCTCTAGACACTTCGGCGGCAAGGACTTT GCGCAAGCTTACACCGCCCGGGTGCAGGC 258
UP1-#12 ATCCTCTAGACACACTGGCCCCGGCCGGCAA GCGCAAGCTTACCCGCCCGGGTGCGGCTGCGC 156
UP1-#16 ATCCTCTAGACTCCAGGAAGCTGTGCACGTG GCGCAAGCTTAGTGGTTACCGCCGACGGGGCG 1146
UP1-#21 ATCCTCTAGACGCCAGGATCGTCGAGAGCAC GCGCAAGCTTACCGATCATCGGTGATCCGT 465
UP1-#23 ATCCTCTAGACAACAGCTCCACCTCCGTCAG GCGCAAGCTTACCGGCGCCGCTGCCGGTTCGC 621
UP1-#24 ATCCTCTAGACAACAGCTCCACCTCCGTCAG GCGCAAGCTTCTACACCGCCCGGGTGCAGGC 750
MAP1025 ATCCTCTAGATTGCCCATGACCGATCAACCGC GCGCAAGCTTCTAGCTCGGCGGGCTTTCGGAG 726
MAP3422c ATCCTCTAGACCGGCGCCGCTGCCGGTTCGC GCGCAAGCTTCATGGACCTGGGTCGTCGAG 873
UpET1 CACCATGGATCAGCGACTCCCGGGT CTACACCGCCCGGGTGCAGGCCGA 1209
UpET2 CACCCTGGGCAAGCAGCTGCAGCGG CTACACCGCCCGGGTGCAGGCCGA 915
UpET4 CACCCTGTCATGGACCTGGGTCGTC CTACACCGCCCGGGTGCAGGCCGA 999
UpET5 CACCTTGCCGTCGCACACGCCACCA CTACACCGCCCGGGTGCAGGCCGA 1047
UpET6 CACCGTGCTGGTTCCAATCCAGCAG CTACACCGCCCGGGTGCAGGCCGA 1158
All primers are listed 5
 –3
 . Nucleotides speciﬁc for cloning purposes are underlined.
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